Financing channel feed – Endpoints News

Financing channel feed

After digging through discards, biotech startup is making a $45M bet it can fix a failed cancer therapy

6 years ago

As sickle cell patients find new options, NEA-founded Imara pitches mid-stage alternative for $86M IPO

6 years ago

RA joins global syndicate to back a $98M round for CANbridge

6 years ago

Drug discovery in HD: Oxford spinoff's mass spectrometry approach scores fresh funding

6 years ago

The top 100 biopharma venture investors at the megabillions deal table

6 years ago

The RAS rush: Revolution Medicines bags remarkable $238M IPO raise, more than doubling original goal

6 years ago

Corey Goodman marshals $105M mega-round for his CD47 upstart, looking to break new ground in PhII

6 years ago

Woodford's embattled investors endure another blow as £550M deal to sell-off biotech holdings falters

6 years ago

Party on: Base editing startup, computational drug discovery experts and CRO bag close to $2B total on their way to Nasdaq

6 years ago

Dutch biotech scores €25M in small molecule bet to tackle lysosomal storage disorders

6 years ago

Real-world data get real dollars: GV, Bain help infuse $100M into Verana Health as pragmatic trial space heats up

6 years ago

French cancer-focused microbiome player is flush with €18M Series B injection

6 years ago

The Sanofi-partnered startup finding clinical trials for the 90%

6 years ago

Q&A with Jorge Conde as Andreessen Horowitz launches $750M bio fund III

6 years ago

F-Prime backs a niche AI software startup hunting lofty goals in $22M Series B

6 years ago

How much does it cost to bootstrap a gene therapy startup? Not too much if you're Jim Wilson, per Passage Bio's $125M IPO filing

6 years ago

Pandemic fears force Chinese biotech to postpone Hong Kong IPO meetings — Bloomberg

6 years ago

Striving for higher res imaging of cells, Harvard team debuts startup with backing from ARCH, Northpond

6 years ago

Black Diamond doubles in value hours into Nasdaq debut, marking hot start to the 2020 IPO run

6 years ago

Doudna-founded CRISPR upstart bags $45M for new Cas research, extends its reach into therapeutics

6 years ago

Cancer-focused Black Diamond vaults on to Nasdaq in $200M+ public debut, marking biggest biotech IPO in 2020 so far

6 years ago

Bruce Booth and Samantha Truex's latest venture aims just above Humira

6 years ago

Merck KGaA spinout gets first funding to bring dual-acting cancer molecules into the clinic

6 years ago

Brexit fears, Woodford woes overshadowed UK biotech and cut 2019 financing by almost half

6 years ago

First page Previous page 103 104 105106107 108 109 Next page Last page